Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.32 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.32 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1967282 | 0.85 | KMT2A (0.39) | ALDH1A1KDM4EPOLBKMT2AMEN1 | |
| SCHEMBL514567 | 0.83 | ALDH1A1 (0.33) | ALDH1A1KDM4EGAAPOLBKMT2A | |
| SCHEMBL514096 | 0.83 | CMA1 (0.37) | ALDH1A1KDM4EGAAPOLBKMT2A | |
| SCHEMBL1964874 | 0.83 | ALDH1A1 (0.34) | ALDH1A1KDM4EGAAPOLBKMT2A | |
| SCHEMBL1966626 | 0.83 | ALDH1A1 (0.37) | ALDH1A1KDM4EGAAKMT2ASLC6A2 | |
| SCHEMBL16862452 | 0.82 | KDM4E (0.34) | ALDH1A1KDM4EGAAPOLBKMT2A | |
| SCHEMBL16862460 | 0.79 | ALDH1A1 (0.38) | ALDH1A1KDM4EKMT2ASLC6A2SLC6A4 | |
| SCHEMBL16862449 | 0.78 | ALDH1A1 (0.38) | ALDH1A1KDM4EKMT2ASLC6A2SLC6A4 | |
| SCHEMBL514316 | 0.78 | ALDH1A1 (0.34) | ALDH1A1KDM4EGAAPOLBKMT2A | |
| SCHEMBL1967251 | 0.78 | ALDH1A1 (0.38) | ALDH1A1KDM4EGAAKMT2ASLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2420493-A1 | HALOALKYLSULFONANILIDE DERIVATIVE | Nissan Chemical Industries, Ltd. (JP) | 2012-02-22 | — | — | EP | disclosed |
| US-20120029187-A1 | HALOALKYLSULFONANILIDE DERIVATIVE | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-02-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120029187-A1 | HALOALKYLSULFONANILIDE DERIVATIVE | CBR3, CBR1, HDHD5 | ALDH1A1 1574/4885KDM4E 3260/4885GAA 4215/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.